Gastric precancerous changes: Carcinogenesis, clinical behaviour immunophenotype study and surveillance

Panminerva Medica

Volumn 48, Issue 2, 2006, Pages 109-118

  Testino, G ^a,b  

^a UNIVERSITY OF GENOA   (Italy)

^b NONE   (Italy)

Author keywords

Gastric atrophy; Gastric dysplasia; Gastritis, chronic; Helicobacter pylori; Intestinal metaplasia; p53; Stomach neoplasms

Indexed keywords

ARTICLE; CELL PROLIFERATION; CHRONIC DISEASE; GASTRITIS; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; IMMUNOLOGY; IMMUNOPHENOTYPING; METAPLASIA; PATHOLOGY; PRECANCER; STOMACH MUCOSA; STOMACH TUMOR; TUMOR SUPPRESSOR GENE;

CELL PROLIFERATION; CHRONIC DISEASE; GASTRIC MUCOSA; GASTRITIS; GENES, P53; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; IMMUNOPHENOTYPING; METAPLASIA; PRECANCEROUS CONDITIONS; STOMACH NEOPLASMS;

EID: 33750547599     PISSN: 00310808     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (62)

1. Pellicano R, Fagoonee S, Palestro G, Rizzetto M, Ponzetto A. Intestinal metaplasia, displasia, gastric cancer and Helicobacter pylori: epidemiological observations. Minerva Med 2005;96:1-10.
2. Rugge M, Cassaro M, Di Mario F, Leo G, Leandro G, Russo VM et al. The long term outcome of gastric non-invasive neoplasia. Gut 2003;52:1111-6.
3. Rugge M, Correa P, Dixon MF, Hattori T, Leandro G, Lewin K et al. Gastric dysplasia. The Padova international classification. Am J Surg Pathol 2000;24:167-76.
4. Cheli R, Testino G, Giacosa A, Cornaggia M. Chronic gastritis: its clinical and physiopathological meaning. J Clin Gastroenterol 1995;21:193-7.
5. Dixon MF, Genta RM, Yardley JH. Classification and grading of gastritis. The uptodate Sydney System. Am J Surg Pathol 1996;20:1161-81.
6. Genta RM, Rugge M. Gastric precancerous lesions: heading for an international consensus. Gut 1999;45 Suppl 1:15-8.
7. Cheli R, Testino G. The problem of the chronic non specific gastritis: classification today. J Clin Gastroenterol 1993;17:265-6.
8. Correa P. A human model for gastric carcinogenesis. Cancer Res 1988;48:3554-60.
9. Correa P. Human gastric carcinogenesis: a multistep and multifactorial process. First American Cancer Society Award Lecture on cancer epidemiology and prevention. Cancer Res 1992;52:6735-40.
10. Testino G, Cornaggia M, Valentini M. Helicobacter pylori, pre-neoplastic changes, gastric cancer: a point of view. Eur J Gastroenterol Hepatol 1999;11:357-9.
11. Testino G, Valentini M, Cornaggia M, Testino R. Chronic atrophic gastritis and gastric cancer. Digest Liver Dis 2000;32:544.
12. Testino G. Gastric acidity and preneoplastic/neoplastic changes of the stomach. Eur J Gastroenterol Hepatol 2000;12:1353-4.
13. Testino G, De Iaco F, Cornaggia M. Role of chronic atrophic gastritis of the body-fundus and achlorydria in the development of epithelial dysplasia and gastric carcinoma. Acta Gastroenterol Belg 2004;67:327-30.
14. Sobala GM, Pignatelli B, Schorah CJ, Bartsch H, Sanderson M, Dixon MF et al. Levels of nitrite, nitrate, N-nitroso compounds, ascorbic acid and total bili acids in gastric juice in patients with and without precancerous conditions of the stomach. Carcinogenesis 1991;12:193-8.
15. Parsonnet J. Helicobacter pylori and gastric cancer. Gastroenterol Clin North Am 1993;22:89-104.
16. Viani F, Siegrist HH, Pignatelli B, Cederberg C, Idstrom JP, Verdu EF et al. The effect of intra-gastric acidity and flora on the contraction of N-nitroso compounds in the stomach. Eur J Gastroenterol Hepatol 2000;12:165-73.
17. Testino G. Anatomical-functional correlations in chronic atrophic gastritis with or without pernicious anemia. Exp Clin Gastroenterol 1993;3:35-9.
18. Cheli R, Testino G. Chronic atrophic gastritis and gastric cancer. Verona: Cortina International; 1993.
19. Filipe MI, Barbatis C, Sandey A, Ma J. Expression of intestinal mucin antigens in the gastric epithelium and its relationship with malignancy. Hum Pathol 1988;19:19-26.
20. Filipe MI, Munoz N, Matko I, Kato I, Pompe-Kirn V, Jutersek A et al. Intestinal metaplasia types and the risk of gastric cancer: a cohort study in Slovenia. Int J Cancer 1994;57:324-9.
21. Genta RM, Gurer IE, Graham DY, Krishnan B, Segura AM, Gutierrez O et al. Adherence of Helicobacter pylori to areas of incomplete intestinal metaplasia in the gastric mucosa. Gastroenterology 1996;111:1206-11.
22. Yuasa Y. Control of gut differentiation and intestinal-type gastric carcinogenesis. Nat Rev 2003;3:592-600.
23. Karam SM, Tomasetto C, Rio MC. Trefoil factor 1 is required for the commitment programme of mouse oxyntic epithelial progenitors. Gut 2004;53:1408-15.
24. Meining A, Morgner A, Bayerdorffer E, Stolte M. Atrophy-metaplasia- dysplasia-carcinoma sequence in the stomach: a reality or merely an hypothesis? Best Pract Res Clin Gastroenterol 2001;15:983-98.
25. Testino G, Cornaggia M. Intestinal metaplasia, high grade epithelial dysplasia and gastric cancer. Scand J Gastroenterol 2002;37:1-2.
26. Semino-Mora C, Doi SQ, Marty A, Simko V, Carlstedt I, Dubois A. Intracellular and interstitial expression of Helicobacter pylori virulence genes in gastric precancerous intestinal metaplasia and adenocarcinoma. J Infect Dis 2003;187:1165-77.
27. Zhang Z, Yuan Y, Gao H, Dong M, Wang L, Gong YH. Apoptosis, proliferation and p53 gene expression of H. pylori associated gastric epithelial lesions. World J Gastroenterol 2001;7:779-82.
28. Panella C, Ierardi E, Polimeno L, Balzano T, Ingrosso M, Amoroso A et al. Proliferative activity of gastric epithelium in the progressive stages of Helicobacter pylori infection. Dig Dis Sci 1996;41:1132-8.
29. Testino G. Helicobacter pylori, cell proliferation, and carcinogenesis. Am J Gastroenterol 2001;96:2514.
30. Lauwers GY. Defining the pathologic diagnosis of metaplasia, atrophy, dysplasia, and gastric adenocarcinoma. J Clin Gastroenterol 2003; 36 Suppl I:S37-S43.
31. Testino G, Cheli R, Cornaggia M. Mucopeptic cell expansion in gastric foveolar epithelium in Helicobacter pylori-positive, body-fundic chronic superficial gastritis. Am J Gastroenterol 1995;90:332-3.
32. Testino G. Body-fundic mucopeptic cells expansion after Helicobacter pylori eradication. Am J Gastroenterol 1998;93:2636-8.
33. Ierardi E, Francavilla A, Balzano T, Panella C. Effect of Helicobacter pylori eradication on gastric epithelial proliferation. Relationship with ras oncogene p21 expression. Ital J Gastroenterol 1997;29: 214-9.
34. Testino G, Cornaggia M, De Iaco F, Gada D. Is it possibile with an immunophenotypic study to foresee the oncologic risk of epithelial gastric dysplasia? Hepatogastroenterology 2002;49:601-3.
35. Fiocca R, Luinetti O, Villani L, Mastracci L, Quilici P, Grillo F et al. Molecular mechanisms involved in the pathogenesis of gastric carcinoma: interactions between genetic alterations, cellular phenotipe and cancer histotype. Hepatogastroenterology 2001;48: 1523-30.
36. Zhou YN, Xu CP, Han B, Li M, Qiao L, Fang DC et al. Expression of E-cadherin and beta-catenin in gastric carcinoma and its correlation with the clinicopathological features and patient survival. World J Gastroenterol 2002;8:987-93.
37. Zhang C, Yamada N, Wu YL, Wen M, Matsuhisa T, Matsukura N. Helicobacter pylori infection, glandular atrophy and intestinal metaplasia in superficial gastritis, gastric erosion, erosive gastritis, gastric ulcer and early gastric cancer. World J Gastroenterol 2005;11: 791-6.
38. Nardone G, Rocco A, Malfertheiner P. Helicobacter pylori and molecular events in precancerous gastric lesions. Aliment Pharmacol Ther 2004;20:261-70.
39. Torrado J, Santisteban A, Ruiz-Ederra J. Genetic susceptibility to gastric cancer. Hepatogastroenterology 2001;48:1544-7.
40. Pei-Fang Ning, Liu HJ, Yuan Y. Dynamic expression of pepsinogen C in gastric cancer, precancerous lesions and Helicobacter pylori associated gastric diseases. World J Gastroenterol 2005;11:2545-8.
41. Yamada H, Ikegami M, Shimoda T, Takagi N, Maruyama M. Long term follow-up study of gastric/adenoma displasia. Endoscopy 2004;36: 390-6.
42. Valle J, Gisbert J. Helicobacter pylori infection and precancerous lesions of the stomach. Hepatogastroenterology 2001;48:1548-51.
43. Kyrlagkitsis I, Karamanolis DG. Premalignant lesions and conditions for gastric adenocarcinomas: diagnosis, management and surveillance guidelines. Hepatogastroenterology 2003;50:592-600.
44. Testino G, Sumberaz A, Delehaye E, Cornaggia M, Valentini M. Gastric high grade dysplasia. Gastroenterology 1999;117:285-6.
45. Goldstein NS, Lewin KJ. Gastric epithelial dysplasia and adenoma: historical review and histological criteria for grading. Human Pathol 1997;28:127-33.
46. Rugge M, Farinati F, Baffa R, Sonego F, Di Mario F, Leandro G et al. Gastric epithelial dysplasia in the natural history of gastric cancer: a multicenter prospective follow-up study. Gastroenterology 1994;107:1288-96.
47. Cats A, Meuwissen SGM, Forman D, Craanen ME, Kuipers EJ. Helicobacter pylori: a true carcinogen? Eur J Gastroenterol Hepatol 1998;10:447-50.
48. Berloco P, Russo F, Cariola F, Gentile M, Giorgio P, Caruso ML et al. Low presence of p53 abnormalities in H. pylori-infected gastric mucosa and in gastric adenocarcinoma. J Gastroenterol 2003;38: 28-36.
49. Baldus SE, Schneider PM, Monig SP, Zirbes TK, Fromm S, Meyer W et al. P21/waf/cipI in gastric cancer: associations with histopathological subtypes, limphonodal metastasis, prognosis and p53 status. Scand J Gastroenterol 2001;36:975-80.
50. Testino G, Cornaggia M. p53 protein expression in epithelial high grade displasia from the stomach. Scand J Gastroenterol 2002;37: 370-2.
51. Testino G, Gada D, De Iaco F, Cornaggia M. p53 and Ki-67 expression in epithelial gastric displasia and in gastric cancer. Panminerva Med 2002;44:369-71.
52. Tong QS, Zheng LD, Wang L, Liu J, Qian W. BAK overexpression mediates p53-independent apoptosis and effects on human gastric cancer cells. BMC Cancer 2004;4:33-40.
53. Hattori T. Development of adenocarcinomas in the stomach. Cancer 1986;57:1528-34.
54. Hattori T, Sugihara H. The pathological sequence in the development of gastric cancer. Scand J Gastroenterol 1996;31 Suppl 214:34-5.
55. Negrini R. Is autoimmunity involved in the relationship between Helicobacterpylori infection, atrophic gastritis and gastric cancer? Ital J Gastroenterol Hepatol 1999;31:842-5.
56. Hirota WK, Zuckerman MJ, Adler DG, Davila RE, Egan J, Leighton JA et al. ASGE guideline: the role of endoscopy in the surveillance of premalignant of the upper gastrointestinal tract. Gastrointest Endosc 2006;63:570-80.
57. Stemmermann GN. Intestinal metaplasia of the stomach. Cancer 1994;74:556-64.
58. Petersson F, Borch K, Franzen LE. Prevalence of subtypes of intestinal metaplasia in the general population and in patients with autoimmune chronic atrophic gastritis. Scand J Gastroenterol 2002;37: 262-6.
59. Genta RM, Rugge M. Pre-neoplastic states of the gastric mucosa-a-practical approach for the perplexed clinician. Aliment Pharmacol Ther 2001;15 Suppl 1:43-50.
60. Rugge M, Russo VM, Guido M. What have we learnt from gastric biopsy? Aliment Pharmacol Ther 2003; 17 Suppl 2:68-74.
61. Hohenberger P, Gretschel S. Gastric cancer. Lancet 2003;362:305-15.
62. Vindigni C, Galgani P. Gastric displasia: classification and clinical characteristic. Minerva Gastroenterol Dietol 2004;50:331-8.